scholarly journals Modelling the Enablers of Green and Sustainable Practices in Indian Pharmaceutical Industry- An ISM Approach

2021 ◽  
pp. 65-74
Author(s):  
Miloni Raiyarela ◽  
Smita Mehendale
Keyword(s):  
Pharmaceutical Industry ◽  
Literature Review ◽  
Environmental Issues ◽  
Pharmaceutical Companies ◽  
Structural Modelling ◽  
Negative Effects ◽  
Management Commitment ◽  
Top Management Commitment ◽  
Level Model ◽  
Indian Pharmaceutical Industry

Rising environmental issues and production of hazardous waste by the pharmaceutical industry has created a harmful impact on society, the environment, and pharmaceutical companies' reputation. It has given rise to the need to adopt and integrate green and sustainable pharmaceutical company’s practices to mitigate environmental degradation's negative effects. The aim is to identify hierarchical interrelationships between these variables and determine their significance through MICMAC analysis and Interpretive Structural Modelling (ISM). The study identified ten significant enablers by exploring literature review and consultation with the industry experts from the Indian Pharmaceutical sector, which led to an understanding of their interrelationships. A four-level model was derived through the ISM technique. Pressure from the customer was found to be the most important enabler, followed by top management commitment and regulation. These enablers carry high driving power. The model developed through this study will help the pharmaceutical companies and their managers to implement green processes systematically.

scholarly journals Effect of Financial Performance on Profitability in Indian Pharmaceutical Companies

2019 ◽  
Vol 8 (6) ◽  
pp. 4910-4916
Keyword(s):  
Pharmaceutical Industry ◽  
Financial Performance ◽  
National Economy ◽  
Pharmaceutical Companies ◽  
Government Control ◽  
Pharmaceutical Sector ◽  
Drug Store ◽  
Indian Pharmaceutical Industry

The total Indian pharmaceutical sector is exceedingly divided with in excess of 20,000 enlisted units. It has spread drastically over the most recent two decades. The pharmaceutical and the chemical industries in India is an amazingly separated market with solid value rivalry and government control. The pharmaceutical business in India meets around 705 of the nation's interest in bulk medications, pharmaceutical formulas, synthetics, tablets, oral and injectables. There are around 250 enormous units and around 8,000 SMUs, which structure the centre of the pharmaceutical business in India, including 4 Pubilc sector units. Looking forward, the worldwide drug store market is assessed at more than to 1.5 billion dollars constantly in 2020. The Indian pharmaceutical industry is growing significantly every year. The primary goal of this research unmistakably demonstrates that pharmaceutical organizations are working great as an industry as well as can add growth to the development of the national economy. In this way, we made an attempt to find the effect of financial performance on profitability.

scholarly journals A Comparative Study of Profitability of Selected Pharma Companies of India

2018 ◽  
Vol 7 (1) ◽  
pp. 27
Author(s):  
Bhavik U. Swadia
Keyword(s):  
Pharmaceutical Industry ◽  
Comparative Study ◽  
Major Change ◽  
Pharmaceutical Companies ◽  
Basic System ◽  
Foreign Product ◽  
Pharmaceutical Manufacturers ◽  
Long Time ◽  
Production Value ◽  
Indian Pharmaceutical Industry

The Indian pharmaceutical industry is growing rapidly in the number of production, value, quantity, units and there are two main things that appear to conform to the story of the full growth of the Indian economy. Second, there has been a major change in the very basic system of pharmaceutical business in India. By issuing a patent ordinance, India fulfills WTO's commitment to identify foreign product patents from January 1, 2005, the culmination of the 10-year process. In this new scenario, Indian pharmaceutical manufacturers will not be able to manufacture patented drugs, which they have been doing for a long time, though by another process. This study has been done for important evaluation of India's pharmaceutical industry. This study focus on to analyse the profitability of the selected pharmaceutical companies of India and to study the relation between the pharmaceutical companies for various measures of profitability. The study period is ten years from 2007-08 to 2016-17. Based on the study it can be seen that pharmaceutical companies had a very good profitability in 2008, while the weakest profitability of all time in year 2015.

The importance of the Polish pharmaceutical market for the economy

2019 ◽  
Vol 32 (3) ◽  
Author(s):  
Katarzyna Pogorzelczyk ◽  
Marta Gallas ◽  
Marlena Robakowska ◽  
Przemysław Żuratyński ◽  
Sylwia Jałtuszewska ◽  
...  
Keyword(s):  
Statistical Analysis ◽  
Pharmaceutical Industry ◽  
Literature Review ◽  
Research Methods ◽  
National Economy ◽  
Global Economy ◽  
Business Models ◽  
Financial Statements ◽  
Pharmaceutical Market ◽  
Pharmaceutical Companies

The pharmaceutical market is one of the most developed sectors of the global economy at present. The largest pharmaceutical companies flexibly are shaping business models, giving up the consolidation and incorporations for forming diversified organizations concentrated on special fields, restructuring one's research-developmental centres. And so analysis of legislative acts, as well as reports and financial statements of the Polish pharmaceutical industry is a purpose of the work – with the pressure on his development, the production, the sale and planned action with reference to the national economy. Contents and materials, based on which they made following analysis, were based above all on data received directly from pharmacies and pharmaceutical companies. Research methods concentrated on the literature review and an own statistical analysis and descriptive.

Linkage between Efficiency of Assets Management and Profitability in Selected Companies in Pharmaceutical Industry

2014 ◽  
pp. 207-221
Author(s):  
Kaushik Chakraborty
Keyword(s):  
Pharmaceutical Industry ◽  
Sample Size ◽  
Asset Management ◽  
Pharmaceutical Companies ◽  
Statistical Tools ◽  
Tools And Techniques ◽  
The Relationship ◽  
Domestic Companies ◽  
Indian Pharmaceutical Industry ◽  
Assets Management

This chapter empirically investigates the relationship between the efficiency of asset management and profitability of the Indian pharmaceutical industry during the period 2002-03 to 2011-12. The chapter also tries to make a comparison, in respect of the efficiency of assets management, between multinational and domestic companies in the Indian pharmaceutical industry during the same period. The sample size of the study consists of 20 pharmaceutical companies by taking 10 multinational and 10 domestic companies from the Indian pharmaceutical industry. The issues analyzed in this study have been tackled using relevant statistical tools and techniques.

scholarly journals A Study of the Impact of Value-Added Efficiency on Profitability and Market Value in the Indian Pharma Industry

2022 ◽  
Vol 11 (1) ◽  
pp. 212
Author(s):  
Shireen Rosario ◽  
Chandra Sen Mazumdar
Keyword(s):  
Pharmaceutical Industry ◽  
Intellectual Capital ◽  
Stock Exchange ◽  
Value Added ◽  
Market Value ◽  
Market Valuation ◽  
Pharmaceutical Companies ◽  
Knowledge Based ◽  
The Impact ◽  
Indian Pharmaceutical Industry

The aim of this paper is to highlight the growing influence of Intellectual Capital (IC) on the profitability and market valuation, especially in knowledge-based industries. The scope of this paper is restricted to the Indian Pharmaceutical Industry, which is highly dependent on IC. This study employs the measure of Value-Added Intellectual Coefficient (VAIC) to assess impact of IC on the profitability and market valuation and to assess the growth of VAIC and its components among the companies over the years selected for the study. The study uses 22 Pharmaceutical companies listed in the Bombay Stock Exchange for a period of 12 years from the financial year 2008-09 to 2019-20. By using Path Analysis, the study demonstrates that the components of VAIC have an impact on the ROCE and market value, which has only grown as compared to earlier studies & years. The study also demonstrates that high sales and profits need not necessarily result in high VAIC.   Received: 7 October 2021 / Accepted: 24 November 2021 / Published: 3 January 2022

scholarly journals Promotion of Indian Drugs in Media

2019 ◽  
Vol 8 (3) ◽  
pp. 3080-3087
Keyword(s):  
Clinical Trials ◽  
Pharmaceutical Industry ◽  
Pharmaceutical Companies ◽  
Good Source ◽  
Competitive Situation ◽  
Pharmaceutical Drug ◽  
The World ◽  
Drug Promotion ◽  
Pharmaceutical Production ◽  
Indian Pharmaceutical Industry

The Indian pharmaceutical industry is very wide and in volume it has been ranked 3rd in the world. It is contributing to 10% of the total pharmaceutical production. In terms of value the pharmaceutical industry is 14th largest in the world. As far as market is concerned it is 1.5% of the total pharmaceutical market. India is a good source of good quality and cheap medicines with strong retail base. It is also a hub for clinical trials, biotechnology, contract research, and clinical data management services. There has been tremendous competition among all pharmaceutical companies. In this competitive situation, media has emerged as a strong tool to promote pharmaceutical drug to end customers. This research paper contributes to the different aspects of pharmaceutical drug promotion in media in India.

Factors Influencing Green Warehouse Practices in Malaysian Warehouse Industry: An Empirical Analysis

2019 ◽  
Vol 5 (1) ◽  
pp. 54
Author(s):  
Siti Norida Wahab ◽  
Nazura Mohamed Sayuti ◽  
Azimah Daud
Keyword(s):  
Industrial Development ◽  
Data Gathering ◽  
Global Market ◽  
Acceptance Rate ◽  
Extensive Literature ◽  
Factors Influencing ◽  
Industry Competition ◽  
Management Commitment ◽  
Top Management Commitment ◽  
The Government

The purpose of this study is to provide an understanding of the factors influencing green warehouse practices (GWP) in the Malaysian warehouse industry. Both stakeholder theory (ST) and institutional theory (IT) act as the foundation in developing the theoretical framework. Six factors were identified resulted from preliminary data gathering and an extensive literature review for constructing the model. The sample size consists of 226 respondents with the acceptance rate of 89 per cent. The findings revealed that customer demand, owner support, employee involvement, top management commitment, industry competition, and governmental pressure are positively associated with GWP. Based on the findings, warehouse companies and relevant authorities in Malaysia should focus on the importance of GWP towards becoming more competitive in the global market. The study provides a theoretical gap by proposing a valuable implication to scholars and practitioners in promoting sustainable industrial development which aligns with the government national agenda.

The Influence of TRIPS Compliant Patent Laws on Indian Pharmaceutical Industry

2014 ◽  
Vol 4 (1) ◽  
Author(s):  
Rupesh Rastogi ◽  
Virendra Kumar
Keyword(s):  
Pharmaceutical Industry ◽  
Patent Protection ◽  
Uruguay Round ◽  
Pharmaceutical Products ◽  
Trips Agreement ◽  
Patent Law ◽  
Patent Laws ◽  
The Impact ◽  
First Time ◽  
Indian Pharmaceutical Industry

The first legislation in India relating to patents was the Act VI of 1856. The Indian Patents and Design Act, 1911 (Act II of 1911) replaced all the previous Acts. The Act brought patent administration under the management of Controller of Patents for the first time. After Independence, it was felt that the Indian Patents & Designs Act, 1911 was not fulfilling its objective. Various comities were constituted to recommend, framing a patent law which can fulfill the requirement of Indian Industry and people. The Indian Patent Act of 1970 was enacted to achieve the above objectives. The major provisions of the act, provided for process, not the product patents in food, medicines, chemicals with a term of 14 years and 5-7 for chemicals and drugs. The Act enabled Indian citizens to access cheapest medicines in the world and paved a way for exponential growth of Indian Pharmaceutical Industry. TRIPS agreement, which is one of the important results of the Uruguay Round, mandated strong patent protection, especially for pharmaceutical products, thereby allowing the patenting of NCEs, compounds and processes. India is thereby required to meet the minimum standards under the TRIPS Agreement in relation to patents and the pharmaceutical industry. India’s patent legislation must now include provisions for availability of patents for both pharmaceutical products and processes inventions. The present paper examines the impact of change in Indian Patent law on Pharmaceutical Industry.

Sign in / Sign up

Export Citation Format

Share Document